YARW
Yarrow Bioscience Inc
NASDAQ · Healthcare · Biotechnology · US
$29.58
+2.53%Margins
Gross margin
97.5%
EBITDA margin
-3910.0%
EBIT margin
-4134.6%
Net margin
-3881.5%
FCF margin
-3513.1%
-84.8%
Return on equity
-79.3%
Return on assets
-90.3%
Return on invested capital
0.02x
Asset turnover
-$16.9M
Cash from operations
$8.59
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026